PAST EVENTS
Microbix Reports Results for Q4 & Full-Year Fiscal 2023
Dec 21, 2023
Full-Year Sales of $16.5 million and Net Loss of $0.04 million MISSISSAUGA, CANADA, December 21, 2023 - Microbix Biosystems Inc. (TSX:...
Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy
Dec 14, 2023
Expanded Collaboration to Improve Syndromic Infectious Disease Testing MISSISSAUGA, CANADA & IRVINE, CALIFORNIA, December 14, 2023 –...
Microbix & BioGX Collaborate on real-time PCR Assays & Controls
Dec 7, 2023
Quality Controls for Respiratory Viral, Pharyngitis, and Genital Ulcer Disease Panels MISSISSAUGA, CANADA & BIRMINGHAM, ALABAMA,...
Microbix Announces Initiation of Normal Course Issuer Bid -2023
Dec 6, 2023
For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, December 6, 2023 - Microbix Biosystems Inc. (TSX:...
Microbix Presenting at Florida Capital Event Conference
Nov 17, 2023
Meetings with Growth-Oriented Investors, November 17 to 19, 2023 MISSISSAUGA, CANADA, November 17, 2023 - Microbix Biosystems Inc. (TSX:...